Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Treasury Shares (2021 - 2025)

LifeStance Health (LFST) has disclosed Treasury Shares for 5 consecutive years, with $1.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Treasury Shares fell 43.77% to $1.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.3 million, a 43.77% decrease, with the full-year FY2025 number at $1.3 million, down 94.72% from a year prior.
  • Treasury Shares was $1.3 million for Q4 2025 at LifeStance Health, down from $26.4 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $30.8 million in Q2 2021 to a low of $5615.0 in Q3 2023.
  • A 5-year average of $8.9 million and a median of $2.3 million in 2024 define the central range for Treasury Shares.
  • Peak YoY movement for Treasury Shares: tumbled 99.95% in 2022, then soared 139087.9% in 2023.
  • LifeStance Health's Treasury Shares stood at $23501.0 in 2021, then dropped by 28.53% to $16796.0 in 2022, then skyrocketed by 139087.9% to $23.4 million in 2023, then crashed by 90.35% to $2.3 million in 2024, then plummeted by 43.77% to $1.3 million in 2025.
  • Per Business Quant, the three most recent readings for LFST's Treasury Shares are $1.3 million (Q4 2025), $26.4 million (Q3 2025), and $27.4 million (Q2 2025).